Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 16 2014

Topics - Biologics, Proteins, Vaccines

Refine by Date:
From: To:
Published September 12, 2014
Aims to meet clinical development needs for all therapeutic areas Read More »
Published September 10, 2014
Genmab to pay $11 million for exclusive rights to Seattle Genetics' ADC technology Read More »
Published September 9, 2014
Plans to double its workforce Read More »
Published August 27, 2014
Training center to aid biopharma companies with manufacturing challenges Read More »
Published August 27, 2014
Patheon gains biologic sites in St. Louis and Princeton Read More »
Published August 25, 2014
Expands respiratory portfolio globally Read More »
Published August 7, 2014
Will support the processing of ADVATE Read More »
Published August 5, 2014
Aims to identify microRNAs as biomarkers for MS Read More »
Published August 5, 2014
Expands development of RNA-targeting molecules Read More »
Published July 1, 2014
Sanofi exercises its options on five pathogens Read More »
Published June 27, 2014
Expands support services for biologics development Read More »
Published June 3, 2014
Gains Alternating Tangential Flow (ATF) System Read More »
Published May 29, 2014
To assess the dosing and performance of a subunit antigen vaccine candidate Read More »
Published May 15, 2014
Two-year contract covers oligonucleotides and DNA sequencing services Read More »
Published May 13, 2014
Expands platform of biologics services Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On